Bengt Arne Gustavsson
Chief Tech/Sci/R&D Officer chez NANEXA AB
Profil
Bengt Arne Gustavsson is currently the Chairman & Chief Executive Officer at Sangus Jazz AB and also serves as an Independent Director & Medical Director at Nanexa AB.
Previously, he held positions such as Director-Nordic Clinical Research at Sanofi Aventis AB from 2005 to 2007, Director-Nordic Medical at Novartis Oncology Switzerland from 2002 to 2005 and from 2007 to 2011, Director at Wntresearch AB, Global Head-Medical Affairs at Oncopeptides AB, and Head-Nordic Medical at Celgene AB from 2012 to 2017.
Dr. Gustavsson obtained a doctorate degree from the University of Uppsala in 1994, an undergraduate degree from the University of Uppsala in 1987, and another undergraduate degree from the University of Basel in 1999.
Postes actifs de Bengt Arne Gustavsson
Sociétés | Poste | Début |
---|---|---|
NANEXA AB | Chief Tech/Sci/R&D Officer | 01/01/2021 |
Sangus Jazz AB | Chief Executive Officer | - |
Anciens postes connus de Bengt Arne Gustavsson
Sociétés | Poste | Fin |
---|---|---|
Celgene AB | Corporate Officer/Principal | 01/01/2017 |
Novartis Oncology Switzerland | Corporate Officer/Principal | 01/01/2011 |
Sanofi Aventis AB
Sanofi Aventis AB Sanofi Aventis AB engages in the pharmaceutical industsry. The company is headquartered in Stockholm, Sweden. | Corporate Officer/Principal | 01/01/2007 |
Novartis Oncology Switzerland | Corporate Officer/Principal | 01/01/2005 |
WNTRESEARCH AB | Director/Board Member | - |
Formation de Bengt Arne Gustavsson
University of Uppsala | Doctorate Degree |
University of Basel | Undergraduate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 3 |
---|---|
ONCOPEPTIDES AB | Health Technology |
WNTRESEARCH AB | Health Technology |
NANEXA AB | Health Technology |
Entreprise privées | 4 |
---|---|
Sanofi Aventis AB
Sanofi Aventis AB Sanofi Aventis AB engages in the pharmaceutical industsry. The company is headquartered in Stockholm, Sweden. | |
Novartis Oncology Switzerland | |
Celgene AB | |
Sangus Jazz AB |